You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cfDNA positive MET alterations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Pittsburgh (Capmatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2023

NSCLC Trial in Chongqing (Aumonertinib 165mg orally once daily and intrathecal chemo with pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer
  • Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
  • Chongqing, China
    chongqing University Three Gorges Hospital
Apr 11, 2023

Noninvasive vs. Invasive Lung Evaluation

Completed
  • Non-Small Cell Lung Cancer
  • Guardant360
  • (no location specified)
Apr 29, 2021

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Bile cfDNA of Resectable Biliary Tract Carcinomas

    Recruiting
    • This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile
    • Next generation sequencing
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
    Mar 13, 2023

    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Amivantamab
    • +3 more
    • (no location specified)
    Oct 30, 2023

    Standard Radiotherapy and TMZ Patients With GBM

    Not yet recruiting
    • Glioblastoma
    • Glioma, Malignant
      • Durham, North Carolina
        The Preston Robert Tisch Brain Tumor Center at Duke University
      Jan 20, 2023

      Lymphoma Trial in Houston (cell-free DNA)

      Not yet recruiting
      • Lymphoma
      • cell-free DNA
      • Houston, Texas
        MD Anderson Cancer Center
      Dec 22, 2022

      Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)

      Active, not recruiting
      • Metastatic Lung Cancer
      • InvisionFirst® molecular panel
      • Bayeux, France
      • +15 more
      Aug 22, 2022

      Tumors Trial (ABN401)

      Not yet recruiting
      • Neoplasms
      • (no location specified)
      May 21, 2023

      Vascular Invasion Signatures in cfDNA Support Re-staging of

      Completed
      • Carcinoma, Hepatocellular
      • +2 more
      • Liver resection
      • Shanghai, Shanghai, China
        Eastern Hepatobiliary Surgery Hospital, Naval Medical University
      Sep 15, 2022

      Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and

      Not yet recruiting
      • Invasive Mammary Carcinoma
      • Metastatic Breast Cancer
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Jan 11, 2023

      NSCLC Trial in Guangzhou (Osimertinib, Savolitinib)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Guangzhou, Guangdong, China
        Guangdong Lung Cancer Institute, Guangdong General Hospital, Gua
      Dec 6, 2021

      Glioblastoma Trial in Beijing (PLB1001, Temozolomide, Cisplatin combined with Etoposide)

      Active, not recruiting
      • Glioblastoma
      • Beijing, Beijing, China
        Beijing Tiantan Hospital,Capital Medical University
      Oct 27, 2023

      Donor Derived Cell-free DNA and Rejection of Kidney Allografts

      Completed
      • Kidney Rejection Transplant
      • Donor-derived cell-free DNA
      • (no location specified)
      Aug 7, 2023

      Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

      Active, not recruiting
      • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
      • +5 more
      • Crizotinib (PF-02341066)
      • Brussels, Belgium
      • +24 more
      May 9, 2022

      Advanced Solid Tumors Trial in Goyang-si, Seoul (ABN401)

      Not yet recruiting
      • Advanced Solid Tumors
      • Goyang-si, Gyeonggi-Do, Korea, Republic of
      • +2 more
      Sep 13, 2022

      Gastric Cancer, Gastroesophageal-junction Cancer Trial in Gyeonggi-do (Tepotinib plus paclitaxel)

      Recruiting
      • Gastric Cancer
      • Gastroesophageal-junction Cancer
      • Tepotinib plus paclitaxel
      • Gyeonggi-do, Korea, Republic of
        Hallym University Medical Center
      Jun 29, 2022

      Obstructive Sleep Apnea Trial in Miami (Motivational Enhancement Therapy, Positive Airway Pressure (PAP) therapy)

      Not yet recruiting
      • Obstructive Sleep Apnea
      • Motivational Enhancement Therapy
      • Positive Airway Pressure (PAP) therapy
      • Miami, Florida
        University of Miami
      Sep 14, 2023

      NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

      Active, not recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Non-small Cell Lung Cancer Stage III
      • La Jolla, California
      • +5 more
      Aug 12, 2022

      Primary Liver Cancer Early Detection

      Recruiting
      • Liver Cancer
      • Liver-cancer early detection test
      • Changchun, Jilin, China
      • +1 more
      Aug 10, 2023

      Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor

      Recruiting
      • Glioblastoma
      • Lumber Puncture
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All protocol activites)
      Jun 28, 2023

      ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

      Recruiting
      • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
      • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
      • Montpellier, France
      • +1 more
      Nov 16, 2022

      LIver, Biliary tRAct and pancReatic Cancers

      Recruiting
      • Liver Cancer
      • +2 more
      • Blood drawing
      • Hangzhou, Zhejiang, China
        The Second Affiliated Hospital, Zhejiang University School of Me
      Nov 14, 2023

      Resistance-associated Mutations in Metastatic Lung Cancer

      Recruiting
      • Lung Cancer
      • Liquid biopsy
      • Monza, MB, Italy
        Fondazione IRCCS San Gerardo dei Tintori
      Oct 10, 2023